New target, intervention for treating melanoma

Boston — New research discoveries demonstrate that melanoma is highly dependent on cyclin-dependent kinase 2 (CDK2) for growth and proliferation. Inhibiting expression of the gene regulating CDK2 stops the cancer dead in its tracks.

Related Videos
Related Content

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.